Intellectual Property India Publishes Patent Application for 'Compositions And Dosage Forms For Treatment Of Hpv Infection And Hpv-Induced Neoplasia' Filed by Antiva Biosciences, Inc.

MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202517014186 A) filed by Antiva Biosciences, Inc., Redwood City, U.S.A., on Feb. 19, for 'compositions and dosage forms for treatment of hpv infection and hpv-induced neoplasia.'

Inventor(s) include Aldous, Barry; Gadiraju, Ramakrishna; Walter, Sarah; Daniels, Oranee; Maderis, Gail; Argade, Ankush; Mahalingam, Ravichandran; Zhao, Zhengle; Qin, Zhaoyang; Jiang, Siyi; and Li, Runyan.

The application for the patent was published on May 9, under issue no. 19/2025.

According to the abstract released by the Intellectual Property India: "A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including ...